tradingkey.logo
tradingkey.logo
検索

NeuroOne Medical Technologies Corp

NMTC
ウォッチリストに追加
1.360USD
0.0000.00%
取引時間 09/18, 14:02ET
11.84M時価総額
損失額直近12ヶ月PER

詳細情報 NeuroOne Medical Technologies Corp 企業名

NeuroOne Medical Technologies Corporation is a medical technology company. It is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, incontinence and artificial intelligence. Its products include Evo cortical electrode technology for recording, monitoring, and stimulating brain tissue for up to 30 days; Evo sEEG electrode technology for temporary (less than 30 days) use with recording, monitoring, and stimulation equipment for the recording, monitoring, and stimulation of electrical signals at the subsurface level of the brain, and OneRF ablation system for creation of radiofrequency lesions in nervous tissue for functional neurosurgical procedures.

NeuroOne Medical Technologies Corp プロフィール

企業コードNMTC
会社名NeuroOne Medical Technologies Corp
上場日Nov 09, 2012
最高経営責任者「CEO」Rosa (David A)
従業員数17
証券種類Ordinary Share
決算期末Nov 09
本社所在地7599 Anagram Dr
都市EDEN PRAIRIE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号55344-7399
電話番号19524261383
ウェブサイトhttps://nmtc1.com/
企業コードNMTC
上場日Nov 09, 2012
最高経営責任者「CEO」Rosa (David A)

NeuroOne Medical Technologies Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Mr. Jeffrey S. (Jeff) Mathiesen, CPA
Independent Director
Independent Director
24.17K
+28.92%
Mr. Mark Christianson
Mr. Mark Christianson
Co-Founder, Business Development Director, Medical Sales Liaison
Co-Founder, Business Development Director, Medical Sales Liaison
23.11K
-43.27%
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. David A. (Dave) Rosa
Mr. David A. (Dave) Rosa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
123.37K
-0.33%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%
Mr. Paul Buckman
Mr. Paul Buckman
Independent Chairman of the Board
Independent Chairman of the Board
40.60K
+17.21%

よくある質問

NeuroOne Medical Technologies Corpの上位5名の株主は誰ですか?

NeuroOne Medical Technologies Corpの上位5名の株主は以下のとおりです。Mr. David A. (Dave) Rosa

NeuroOne Medical Technologies Corp(NMTC)の株式を保有している機関の数はいくつですか?

2026Q1時点で、NeuroOne Medical Technologies Corpの株式を保有している機関は58社あり、保有株式の総市場価値は約2.36Mで、全体の28.07%を占めています。2025Q4と比較して、機関の持ち株は-230396.00増加しています。
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。